Porda Havas International Financial Communications Group
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Ping An of China Asset Management (Hong Kong) Awarded "Asset Management Firm of the Year" at Asia Risk Awards 2020 2020-09-08 19:00
Viva Biotech Announced 2020 Interim Results 2020-08-31 23:27
SDIC leads the investment of Xuanzhu Biopharmaceutical with RMB 800 million, promoting innovation and R&D 2020-08-24 10:20
Sihuan Pharmaceutical Introduced Investors for Capital Increase to Accelerate Solid-liquid Double Chamber Infusion Soft Bag Industry 2020-08-20 19:39
Ping An of China Asset Management (Hong Kong) Launches First Co-branded Fund with Hang Seng Investment Management 2020-08-18 16:00
Lee's Pharm Announced 2020 Interim Results Positive Profit Alert 2020-08-14 23:49
Viva Biotech and Langhua Pharmaceutical Reached the Strategic Acquisition Agreement, Accelerating the Escalation of the Service Chain of Innovative Drug Industry 2020-08-10 08:00
Viva Biotech and Schrödinger Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets 2020-07-29 07:00
New Licensing Agreement Accelerates the Development of IACTA Pharmaceuticals' Novel Dry Eye Disease and Allergic Conjunctivitis Treatments in China and Southeast Asia 2020-07-28 17:59
Venus Medtech to Partner with Pi-Cardia to Bring its Leaflex(TM) Aortic Valve Technology to China 2020-07-14 18:19
Viva BioInnovator (VBI) Successfully Held 1st Demo Day 2020-06-17 16:40
Venus Medtech and Opus Medical Therapies, LLC Announce Partnership for Transcatheter Mitral Valve Replacement (TMVR) and Transcatheter Tricuspid Valve Replacement (TTVR) in Greater China Market 2020-05-02 16:54
Viva Biotech Announced 2019 Annual Results 2020-03-31 11:45
SMIT Announces 2019 Annual Results 2020-03-30 10:54
Drug Registration Approval Granted for Sihuan Pharmaceutical's Pediatric Compound Amino Acid Injection (18AA-II) 2020-03-23 17:57
Huize Holding Limited Announces Partial Exercise of Over-Allotment Option in Initial Public Offering 2020-03-11 10:16
Sihuan Pharmaceutical Announces Clinical Research of Favipiravir, Co-Developed with the Academy of Military Medical Sciences of the People's Liberation Army, Has Commenced 2020-03-02 14:15
Ping An of China Asset Management (Hong Kong) Becomes the First Asian Institutional Investor to Partner with CBI 2020-03-02 09:51
Sihuan Pharmaceutical Announces Acquisition of All Interests and Intellectual Property Rights of Plazomicin, A New Generation of Aminoglycoside Antibiotics in the Greater China Region 2020-02-20 18:59
Announcement of Memorandum of Understanding for Launching Strategic joint venture of 5G network service business 2020-02-19 17:00
1 4 5 6 7 8 17